Rapamycin resistance tied to defective regulation of p27(Kip1)

Molecular and Cellular Biology

Volumn 16, Issue 12, 1996, Pages 6744-6751

  Luo, Yan ^a,b   Marx, Steven O ^c   Kiyokawa, Hiroaki ^a,b   Koff, Andrew ^b   Massagué, Joan ^b   Marks, Andrew R ^c,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d AMERICAN HEART ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYTOSOL RECEPTOR; MITOGENIC AGENT; PROTEIN KINASE INHIBITOR; RAPAMYCIN; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG RESISTANCE; EMBRYO; FIBROBLAST; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE TARGETING; GROWTH INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALIA; MURINAE;

EID: 0029977949     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.12.6744     Document Type: Article

References (52)

1. Albers, M., R. Williams, E. Brown, A. Tanaka, F. Hall, and S. Schreiber. 1993. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell. J. Biol. Chem. 268:22825-22829.
2. Bose, R., M. Verheij, A. Haimovitz-Friedman, K. Scotto, Z. Fuks, and R. Kolesnick. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
3. Brown, E., M. Albers, T. Shin, K. Ichikawa, C. Keith, W. Lane, and S. Schreiber. 1994. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (London) 369:756-758.
4. Brown, E. J., P. A. Beal, C. T. Keith, J. Chen, T. B. Shin, and S. L. Schreiber. 1995. Control of p70 S6 kinase by kinase activity of FRAP in vivo. Nature (London) 377:441-446.
5. Cafferkey, R., P. R. Young, M. M. McLaughlin, U. J. Bergsma, Y. Koltin, G. M. Sathe, L. Faucette, W.-K. Eng, R. K. Johnson, and G. P. Livi. 1993. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 13:6012-6023.
6. Calvo, V., M. Wood, C. Gjertson, T. Vik, and B. E. Bierer. 1994. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation. Eur. J. Immunol. 24:2664-2671.
7. Cheatham, L., M. Monfar, M. M. Chou, and J. Blenis. 1995. Structural and functional analysis of pp70S6k. Proc. Natl. Acad. Sci. USA 92:11696-11700.
8. Chou, M. M., and J. Blenis. 1995. The 70kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol. 7:806-814.
9. Chung, J., T. C. Grammer, K. P. Lemon, A. Kazlauskas, and J. Blenis. 1994. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3OH kinase. Nature (London) 370:71-75.
10. Chung, J., C. J. Kuo, G. R. Crabtree, and J. Blenis. 1992. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling the 70 kd S6 protein kinases. Cell 69:1227-1236.
11. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1QA, which is inhibited by E1B. Genes Dev. 7:546-554.
12. DeCaprio, J. A., Y. Furukawa, F. Ajchenbaum, J. D. Griffin, and D. M. Livingston. 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during the cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89:1795-1798.
13. Dumont, F. J., A. Altmeyer, C. Kastner, P. A. Fischer, K. P. Lemin, J. Chung, J. Blenis, and M. J. Staruch. 1994. Relationship between multiple biologic effects of rapamycin and the inhibition of pp70S6 protein kinase activity. J. Immunol. 152:992-1003.
14. Dumont, F. J., M. J. Staruch, T. Grammer, J. Blenis, C. A. Kastner, and K. M. Rupprecht. 1995. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma. Cell. Immunol. 163:70-79.
15. +2 associated with apoptosis. Methods Cell Biol. 46:43-46.
16. Ewen, M., H. Sluss, L. Whilehouse, and D. Livingston. 1993. TGFβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020.
17. Kip1-deficient mice. Cell 85:733-744.
18. Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-3-induced cell cycle arrest. Nature (London) 371:257-261.
19. Heitman, J., N. R. Movva, and M. N. Hall. 1991. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253:905-909.
20. Hengst, L., and S. I. Reed. 1996. Translational control of p27kip1 accumulation during the cell cycle. Science 271:1861-1864.
21. Jayaraman, T., A.-M. B. Brillantes, A. P. Timerman, H. Erdjument-Bromage, S. Fleischer, P. Tempst, and A. R. Marks. 1992. FK506 Binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267:9474-9477.
22. Jayaraman, T., and A. R. Marks. 1993. Rapamycin-FKBP blocks proliferation induces differentiation and inhibits cdc2 kinase activity in a myogenic cell line. J. Biol. Chem. 268:25385-25388.
23. Kato, J., M. Matsuoka, K. Polyak, J. Massagué, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase-4 activation. Cell 79:487-496.
24. Kip1. Cell 85:721-732.
25. Kozma, S. C., and G. Thomas. 1994. p70S6K/p85S6K: mechanism of activation and role in mitogenesis. Cancer Biol. 5:255-266.
26. Kunz, J., R. Henriquez, U. Schneider, M. Deuter-Reinhard, N. R. Movva, and M. N. Hall. 1993. Target of rapamycin in yeast, TOR2, is an essential phospatidylinositol kinase homolog required for G1 progression. Cell 73: 585-596.
27. Kuo, C. J., J. Chung, D. F. Fiorentino, W. M. Flanagan, J. Blenis, and G. R. Crabtree. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature (London) 358:70-73.
28. Lane, H. A., A. Fernandez, J. C. Lamb, and G. Thomas. 1993. p70s6K function is essential for G1 progression. Nature (London) 363:170-172.
29. Kip1 in neurons. Proc. Natl. Acad. Sci. USA 93:3259-3263.
30. Like, B., and J. Massagué. 1986. The antiproliferative effect of type β transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261:13426-13429.
31. Liu, M., M.-H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman. 1996. Transcriptional activation of the Cd inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:142-153.
32. Lorenz, M. C., and J. Heitman. 1995. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 270:27531-27537.
33. Marx, S. O., T. Jayaraman, L. O. Go, and A. R. Marks. 1995. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ. Res. 76:412-417.
34. Morgan, D. O. 1995. Principles of CDK regulation. Nature (London) 374: 131-134.
35. Morice, W. G., G. J. Brunn, G. Wiederrecht, J. J. Siekierka, and R. T. Abraham. 1993. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J. Biol. Chem. 268:3734-3738.
36. Kip1 display increased body size, multiple organ hyperplasia retinal dysplasia, and pituitary tumors. Cell 85:707-720.
37. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. Lee, J. Massagué, G. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (London) 372:570-573.
38. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
39. Polyak, K., M. H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massagué. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
40. Poon, R. Y. C., H. Toyoshima, and T. Hunter. 1995. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6:1197-1213.
41. Price, D. J., J. R. Grove, V. Calvo, J. Avruch, and B. E. Bierer. 1992. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257:973-977.
42. Qin, X., D. Livingston, W. Kaelin, and P. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
43. Reynisdóttir, I., K. Polyak, A. Iavaronne, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-13. Genes Dev. 9:1831-1845.
44. Robertson, E. J. 1987. Embryo-derived stem cell lines, p. 71-112. In E. J. Robertson (ed.), Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford.
45. Sabatini, D., H. Erdjument-Bromage, M. Lui, P. Tempst, and S. Snyder. 1994. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35-43.
46. Schreiber, S. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283-287.
47. Schubert, D., A. J. Harris, C. E. Devine, and S. and Heinemann. 1974. Characterization of a unique muscle cell line. J. Cell Biol. 61:398-413.
48. Shan, B., and W. H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166-8173.
49. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
50. Slingerland, J. M., L. Hengst, C. Pan, D. Alexander, M. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683-3694.
51. Toyoshima, H., and T. Hunter. 1994. p27, novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
52. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.